Covid-19 roundup: Gener­ic Mer­ck pill to be made for low­er-in­come coun­tries; Gavi says it needs a $5B boost — re­port

The UN-backed Med­i­cines Patent Pool has inked deals with 27 gener­ic man­u­fac­tur­ing com­pa­nies to make cheap­er ver­sions of Mer­ck’s Covid-19 an­tivi­ral mol­nupi­ravir for dis­tri­b­u­tion in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER